Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Lentini

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Scientific Reports|April 15, 2026
Rescuing TP53 from nonsense: novel triazoles for translational readthrough via optimized drug designDavide Ricci, Michele Menditto, Giulia Culletta, et al.
European Journal of Medicinal Chemistry|July 6, 2015
Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivativesIvana Pibiri, Laura Lentini, Raffaella Melfi, et al.
Molecular Pharmaceutics|February 4, 2014
Toward a rationale for the PTC124 (Ataluren) promoted readthrough of premature stop codons: a computational approach and GFP-reporter cell-based assayLaura Lentini, Raffaella Melfi, Aldo Di Leonardo, et al.
European Journal of Medicinal Chemistry|October 3, 2018
Rescuing the CFTR protein function: Introducing 1,3,4-oxadiazoles as translational readthrough inducing drugsIvana Pibiri, Laura Lentini, Raffaella Melfi, et al.
BMC Veterinary Research|June 20, 2018
Pharmacokinetics of rectal levetiracetam as add-on treatment in dogs affected by cluster seizures or status epilepticusGiulia Cagnotti, Rosangela Odore, Giulia Gardini, et al.
IUBMB Life|May 27, 2025
Advancing Therapeutic Strategies for Nonsense-Related Diseases: From Small Molecules to Nucleic Acid-Based InnovationsDavide Ricci, Ilenia Cruciata, Ignazio Fiduccia, et al.
IUBMB Life|June 6, 2025
Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An OverviewEmanuele Vitale, Davide Ricci, Federica Corrao, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Pharmacophore-Based Design of New Chemical Scaffolds as Translational Readthrough-Inducing Drugs (TRIDs)Marco Tutone, Ivana Pibiri, Riccardo Perriera, et al.
Neurology. Genetics|May 1, 2026
Long-Read HiFi Genome Sequencing Resolves Retrotransposon-Mediated Deletions in TANGO2 Deficiency DisorderQuentin Sabbagh, Felipe Villa Tobón, Zahra Kazemi, et al.
Nutrients|February 26, 2022
Preventive Impact of Long-Term Ingestion of Chestnut Honey on Glucose Disorders and Neurodegeneration in Obese MiceSimona Terzo, Pasquale Calvi, Domenico Nuzzo, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Scientific Reports|April 15, 2026
Rescuing TP53 from nonsense: novel triazoles for translational readthrough via optimized drug designDavide Ricci, Michele Menditto, Giulia Culletta, et al.
European Journal of Medicinal Chemistry|July 6, 2015
Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivativesIvana Pibiri, Laura Lentini, Raffaella Melfi, et al.
Molecular Pharmaceutics|February 4, 2014
Toward a rationale for the PTC124 (Ataluren) promoted readthrough of premature stop codons: a computational approach and GFP-reporter cell-based assayLaura Lentini, Raffaella Melfi, Aldo Di Leonardo, et al.
European Journal of Medicinal Chemistry|October 3, 2018
Rescuing the CFTR protein function: Introducing 1,3,4-oxadiazoles as translational readthrough inducing drugsIvana Pibiri, Laura Lentini, Raffaella Melfi, et al.
BMC Veterinary Research|June 20, 2018
Pharmacokinetics of rectal levetiracetam as add-on treatment in dogs affected by cluster seizures or status epilepticusGiulia Cagnotti, Rosangela Odore, Giulia Gardini, et al.
IUBMB Life|May 27, 2025
Advancing Therapeutic Strategies for Nonsense-Related Diseases: From Small Molecules to Nucleic Acid-Based InnovationsDavide Ricci, Ilenia Cruciata, Ignazio Fiduccia, et al.
IUBMB Life|June 6, 2025
Nonsense Mutations in Rare and Ultra-Rare Human Disorders: An OverviewEmanuele Vitale, Davide Ricci, Federica Corrao, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
Pharmacophore-Based Design of New Chemical Scaffolds as Translational Readthrough-Inducing Drugs (TRIDs)Marco Tutone, Ivana Pibiri, Riccardo Perriera, et al.
Neurology. Genetics|May 1, 2026
Long-Read HiFi Genome Sequencing Resolves Retrotransposon-Mediated Deletions in TANGO2 Deficiency DisorderQuentin Sabbagh, Felipe Villa Tobón, Zahra Kazemi, et al.
Nutrients|February 26, 2022
Preventive Impact of Long-Term Ingestion of Chestnut Honey on Glucose Disorders and Neurodegeneration in Obese MiceSimona Terzo, Pasquale Calvi, Domenico Nuzzo, et al.
Pageof 5